REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
05/24/2025
Back to search
Official data from USPTO
EVALAR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
05/25/2025
Trademark type
Combined
Nice classes
3, 5
Filing date
07/09/2014
Registration date
05/24/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2022
Last transaction
05/25/2025
Responsible office
United States Patent and Trademark Office
Status code
708
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
RU-659332 Altai Territory, RU
Examiner
JOINER, KATINA
Law office
L40
Mark description
The mark consists of the term "EVALAR" in white inside a green stylized leaf design with a white swoop design beneath the letters "VALA" in the term "EVALAR".
Holders and representatives
Holders
Zakrytoe aktsionernoe obshchestvo "Evalar"
Representatives
Elise Tenen-Aoki TA IP Law, P.C. A Law Corporation
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Greases for cosmetic purposes; cosmetic creams; hair lotions; lotions for cosmetic purposes; beauty masks; oils for cosmetic purposes; essential oils; cleansing milk for toilet purposes; cosmetic preparations for baths; non-medicated mouthwash; cosmetic preparations for slimming purposes; sunscreen preparations; potpourri; cosmetic sun-tanning preparations; cosmetic preparations for skin care; cosmetics; shampoos; extracts of flowers sold as components of cosmetics; ethereal essences and extracts of herbs for cosmetic purposes
Class 5
Analgesics; antibiotics; balms for medical purposes; dietary fiber for use as an ingredient in the manufacture of dietary supplements; mineral food supplements; nutritional supplements; medicinal roots; collodion for pharmaceutical purposes; licorice for pharmaceutical purposes; candy for medical purposes; medicines for alleviating constipation; liniments; antibiotic ointments; medicinal oils for the treatment of skin diseasesfor use as medicated skin care preparationsas medicated hair care preparations; drugs for medical purposesantimicrobial preparations for inhibiting microbiological decomposition in foodbeverages and pharmaceuticals; medicines for human purposespharmaceutical preparations for treating of disorders of gastrointestinal system; medicinal drinks; flour for pharmaceutical purposes; mint for pharmaceutical purposes; medicinal infusions for treating of disorders of the nervousimmunecardiovascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatologyophthalmology; decoctions for pharmaceutical purposes for treating of disorders of the nervousimmunecardio-vascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatologyophthalmology; food for babies; vitamin preparations; hemorrhoid treatment preparations; eye-washes; pharmaceutical preparations for treating dandruff; pharmaceutical preparations for skin care; medicinal hair growth preparations; preparations of trace elements for human use for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardlo-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genito-urinary systemthe gastro-intestinal systemfor use as dietetic supplementsnutritional additives for medical purposes; pharmaceutical preparations for the treatment of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe rnusculo-skeletal systemthe genito-urinary systemthe gastro-intestinal systemfor the treatment of inflammatory disordersfor use in dermatology; enzyme preparations for medical purposes for the treatment of disorders of gastro-intestinal system; chemico-pharmaceutical preparations for the treatment of disorders of the nervous systemthe immune systemthe vascular and metabolic systemsthe respiratory and genito-urinary systemsmusculoskeletal and inflammatory disorders or for use in dermatologyophthalmologyfor gastro-enterologyfor the prevention and treatment of ocular disordersfor use as anti-infectiveantiparasiticantibioticanti-bacterialantiviral and antifungal; chemical preparations for pharmaceutical or medical purposesfor the treatment of disorders of the nervous systemthe immune systemthe vascular and metabolic systemsthe respiratory and genito-urinary systemsmusculoskeletal and inflammatory disorders or for use in dermatologyophthalmologyfor gastro-enterologyfor the prevention and treatment of ocular disordersfor use as anti-infectiveantiparasiticantibioticanti-bacterialantiviral and antifungal; collyrium; dietetic foodscrackers adapted for medical use; by-products of the processing of cereals for medical purposes; propolis for medicinal or therapeutic purposes; asthmatic tea; linseed dietary supplements ; syrups for pharmaceutical purposes for the treatment of cough; soporifics; bath salts for medical purposes; malt for pharmaceutical purposes; medicinal alcohol; appetite suppressants for medical purposes; medical preparations for slimming purposes; mouthwashes for medical purposes; febrifuges; purgatives; antiparasitic preparations; sedatives; tranquilizers; laxatives; digestives for pharmaceutical purposes; appetite suppressant pills; slimming pills; medicinal herbs; charcoal for pharmaceutical purposes; enzymes for medical purposes; medicinal tea; herbal teas for medicinal purposes; plant and herb extracts for medicinal purposes; elixirspharmaceutical preparations for the treating of disorders of the nervousimmunecardio-vascular and metabolic systemsthe gastro-intestinal systemthe respiratory and genito-urinary systemsmusculo-skeletal and inflammatory disordersfor use in dermatology
Publications
History of USPTO decisions and trademark events.
51 publications found
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/19/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
01/31/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
12/07/2022
XXCR
GENERIC MADRID TRANSACTION CREATED
12/07/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
11/11/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
03/11/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
03/11/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
08/12/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/14/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/14/2021
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/14/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/14/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/14/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/14/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/21/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/25/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
08/25/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/24/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
05/24/2016
PUBO
PUBLISHED FOR OPPOSITION
03/08/2016
GPNX
NOTIFICATION PROCESSED BY IB
03/04/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/17/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/17/2016
NPUB
NOTICE OF PUBLICATION
02/17/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/02/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/01/2016
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/30/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/30/2016
PAPER RECEIVED
01/27/2016
CNRT
NON-FINAL ACTION MAILED
12/03/2015
CNRT
NON-FINAL ACTION WRITTEN
12/02/2015
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
11/16/2015
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
11/10/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/28/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2015
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/05/2015
ALIE
ASSIGNED TO LIE
09/25/2015
PAPER RECEIVED
09/10/2015
RFNT
REFUSAL PROCESSED BY IB
06/07/2015
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/21/2015
RFRR
REFUSAL PROCESSED BY MPU
05/21/2015
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/21/2015
CNRT
NON-FINAL ACTION WRITTEN
05/20/2015
MAFR
APPLICATION FILING RECEIPT MAILED
05/19/2015
DOCK
ASSIGNED TO EXAMINER
05/16/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/15/2015
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/15/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/14/2015
Continuous trademark protection
Get notified about every new filing that threatens EVALAR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.